Speaker illustration

Doctor Moritake Iguchi

Kyoto Medical Centre, Kyoto (Japan)

Member of:

Heart Failure Association

Association of beta blocker use with new-onset heart failure and mortality in atrial fibrillation without pre-existing heart failure: the Fushimi AF registry

Event: ESC Congress 2022

Topic: Prevention

Session: Chronic heart failure and atrial fibrillation

Thumbnail

Vascular endothelial factor C and D in patients with heart failure with preserved, mildly reduced, and reduced ejection fraction: the PREHOSP-CHF Study

Event: ESC Congress 2022

Topic: Biomarkers

Session: Biomarkers for heart failure 1

Thumbnail

Distinct association of VEGF-C and VEGF-D with prognosis in patients with chronic heart failure: the PREHOSP-CHF Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Chronic heart failure e-posters

Thumbnail

Association of low total cholesterol level with clinical outcomes in patients with atrial fibrillation: The Fushimi AF registry

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation e-posters

Thumbnail

Impact of anemia on the relationship between vascular endothelial growth factor C and mortality in patients with suspected or known coronary artery disease: a subanalysis of the ANOX study

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease (Chronic) ePosters

Thumbnail

The relationship between pulse rate and the risk of cardiac events in patients with atrial fibrillation: the Fushimi AF registry

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmias and devices in heart failure

Thumbnail

Low vascular endothelial growth factor-C was a predictor for cardiovascular events in patients with atrial fibrillation and suspected or known coronary artery disease: a subanalysis of the ANOX study

Event: ESC Congress 2019

Topic: Mechanisms for Heart Failure and Cardiac Complications

Session: Epidemiology of atrial fibrillation

Thumbnail

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with a history of heart failure: a subanalysis of the ANOX study

Event: ESC Congress 2019

Topic: Comorbidities

Session: Biomarkers in heart failure

Thumbnail

Serum-amyloid-A/LDL complex independently correlated with angiographic severity of coronary artery disease in patients with cancer: baseline data from the ANOX study

Event: ESC Congress 2017

Topic: CAD and comorbidities

Session: CAD and comorbidities

Thumbnail

Prognostic effect of beta-blockers in patients with atrial fibrillation and heart failure: The Fushimi AF Registry

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb